A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...

Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a biotechnology company pioneering ...

Dr. Georg Winter explores how chemical neomorphs can give proteins new functions by reshaping their cellular interactions, ...

Your gut bacteria are far smarter than you might think. While we've long known that different foods can shift the balance of ...

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke ...

Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

Tr1X, Inc., a clinical-stage autoimmune and inflammatory disease company developing Type 1 regulatory T (Tr1) cell therapies, today announced two oral presentations at the American Society of Gene and ...

A new meeting report was published in Volume 18 of Aging-US on April 6, 2026, titled "Toward actionable interventions in ...

Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...